These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 2849799)

  • 1. Correlation between serum tumor marker levels and tumor proliferation in small cell lung cancer.
    Lehtinen M; Wigren T; Lehtinen T; Kallioniemi OP; Aine R; Aaran RK; Ojala A
    Tumour Biol; 1988; 9(6):287-92. PubMed ID: 2849799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and serologic markers of stage and prognosis in small cell lung cancer. A multivariate analysis.
    Gronowitz JS; Bergström R; Nôu E; Påhlman S; Brodin O; Nilsson S; Källander CF
    Cancer; 1990 Aug; 66(4):722-32. PubMed ID: 2167141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum neuron-specific enolase and lactate dehydrogenase as predictors of response to chemotherapy and survival in non-small cell lung cancer.
    van Zandwijk N; Jassem E; Bonfrer JM; Mooi WJ; van Tinteren H
    Semin Oncol; 1992 Feb; 19(1 Suppl 2):37-43. PubMed ID: 1329221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Tc-99m sestamibi, serum neuron-specific enolase and lactate dehydrogenase as predictors of response to chemotherapy in small cell lung cancer.
    Lim SC; Park KO; Kim YC; Na KJ; Song H; Bom HS
    Cancer Biother Radiopharm; 2000 Aug; 15(4):381-6. PubMed ID: 11041023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum vascular endothelial growth factor levels correlate better with tumour stage in small cell lung cancer than albumin, neuron-specific enolase or lactate dehydrogenase.
    Mall JW; Schwenk W; Philipp AW; Meyer-Kipker C; Mall W; Muller J; Pollmann C
    Respirology; 2002 Jun; 7(2):99-102. PubMed ID: 11985730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuron specific enolase, carcinoembryonic antigen and lactate dehydrogenase as indicators of disease activity in small cell lung cancer.
    Jørgensen LG; Hansen HH; Cooper EH
    Eur J Cancer Clin Oncol; 1989 Jan; 25(1):123-8. PubMed ID: 2537729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prognostic value of the serum neuron specific enolase and lactate dehydrogenase in small cell lung cancer patients receiving first-line platinum-based chemotherapy.
    Liu X; Zhang W; Yin W; Xiao Y; Zhou C; Hu Y; Geng S
    Medicine (Baltimore); 2017 Nov; 96(46):e8258. PubMed ID: 29145241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum neuron-specific enolase is a useful tumor marker for small cell lung cancer.
    Burghuber OC; Worofka B; Schernthaner G; Vetter N; Neumann M; Dudczak R; Kuzmits R
    Cancer; 1990 Mar; 65(6):1386-90. PubMed ID: 2155054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LDH or NSE or LDH and NSE as pretreatment prognostic factors in small cell lung cancer? A commentary.
    Østerlind K
    Lung Cancer; 2000 Oct; 30(1):51-3. PubMed ID: 11008009
    [No Abstract]   [Full Text] [Related]  

  • 10. Serum neuron-specific enolase (S-NSE) in progressive small-cell lung cancer (SCLC).
    Jørgensen LG; Osterlind K; Hansen HH; Cooper EH
    Br J Cancer; 1994 Oct; 70(4):759-61. PubMed ID: 7917935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumour markers for prediction of survival and monitoring of remission in small cell lung cancer.
    Johnson PW; Joel SP; Love S; Butcher M; Pandian MR; Squires L; Wrigley PF; Slevin ML
    Br J Cancer; 1993 Apr; 67(4):760-6. PubMed ID: 8385978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuron-specific enolase, thymidine kinase, and tissue polypeptide-specific antigen in diagnosis and response to chemotherapy of small-cell lung cancer.
    Abbasciano V; Sartori S; Trevisani L; Nielsen I; Ferrazzi E; Bononi A; Toso S; Crepaldi G; Bianchi MP; Gilli G; Zavagli G
    Cancer Detect Prev; 1999; 23(4):309-15. PubMed ID: 10403902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Utility of NSE, ProGRP and LDH in Diagnosis and Treatment
in Patients with Small Cell Lung Cancer].
    Peng Y; Wang Y; Li J; Hao X; Hu X
    Zhongguo Fei Ai Za Zhi; 2016 Sep; 19(9):590-4. PubMed ID: 27666548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ProGRP and NSE in therapy monitoring in patients with small cell lung cancer.
    Wójcik E; Kulpa JK; Sas-Korczyńska B; Korzeniowski S; Jakubowicz J
    Anticancer Res; 2008; 28(5B):3027-33. PubMed ID: 19031951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prognostic influence of serum neuron specific enolase in small cell lung cancer.
    Jørgensen LG; Osterlind K; Hansen HH; Cooper EH
    Br J Cancer; 1988 Dec; 58(6):805-7. PubMed ID: 2852029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum neuron-specific enolase and immunohistochemical markers of neuroendocrine differentiation in lung cancer.
    O'Shea P; Cassidy M; Freaney R; McCarthy P; Fennelly J
    Ir J Med Sci; 1995 Jan; 164(1):31-6. PubMed ID: 7890531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of serum thymidine kinase, tissue polypeptide antigen and neuron specific enolase in patients with small cell lung cancer.
    van der Gaast A; van Putten WL; Oosterom R; Cozijnsen M; Hoekstra R; Splinter TA
    Br J Cancer; 1991 Aug; 64(2):369-72. PubMed ID: 1654076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative prognostic value of lactate dehydrogenase and neuron-specific enolase in small-cell lung cancer patients treated with platinum-based chemotherapy.
    Quoix E; Purohit A; Faller-Beau M; Moreau L; Oster JP; Pauli G
    Lung Cancer; 2000 Nov; 30(2):127-34. PubMed ID: 11086206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum neuron-specific enolase (S-NSE) and the prognosis in small-cell lung cancer (SCLC): a combined multivariable analysis on data from nine centres.
    Jørgensen LG; Osterlind K; Genollá J; Gomm SA; Hernández JR; Johnson PW; Løber J; Splinter TA; Szturmowicz M
    Br J Cancer; 1996 Aug; 74(3):463-7. PubMed ID: 8695366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thymidine kinase 1 combined with CEA, CYFRA21-1 and NSE improved its diagnostic value for lung cancer.
    Jiang ZF; Wang M; Xu JL
    Life Sci; 2018 Feb; 194():1-6. PubMed ID: 29247745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.